Victory Capital (NASDAQ:VCTR – Free Report) had its price objective raised by JPMorgan Chase & Co. from $87.00 to $101.00 in a research report released on Friday morning,Benzinga reports. The firm currently has a neutral rating on the stock. VCTR has been the topic of several other reports. Zacks Research upgraded shares of Victory Capital […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Target (NYSE:TGT) Price Target Raised to $157.00 | 0 | 13.85 | 10-08-2026 |
| 2 | Natera (NASDAQ:NTRA) Price Target Raised to $360.00 | 0 | 14.27 | 10-08-2026 |
| 3 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 4 | Cabot (NYSE:CBT) Price Target Raised to $78.00 | 0 | 14.69 | 10-08-2026 |
| 5 | Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00 | 0 | 14.22 | 10-08-2026 |
| 6 | JPMorgan Chase & Co. Cuts Zoetis (NYSE:ZTS) Price Target to $115.00 | 0 | 12.26 | 10-08-2026 |
| 7 | Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00 | 0 | 12.25 | 10-08-2026 |
| 8 | Centrus Energy (NYSE:LEU) Price Target Raised to $180.00 | 0 | 13.43 | 10-08-2026 |
| 9 | Cadre (NYSE:CDRE) Price Target Raised to $45.00 | 0 | 13.85 | 10-08-2026 |
| 10 | Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) Price Target Raised to $125.00 | 0 | 12.59 | 10-08-2026 |